Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea

Joo Sung Shim,1 Youhyun Kim,1 Taeho Yuh,1 Jii Bum Lee,2 Hye Ryun Kim,2 Min Hee Hong,2 Byoung Chul Cho,2 Sun Min Lim2 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shim JS, Kim Y, Yuh T, Lee JB, Kim HR, Hong MH, Cho BC, Lim SM
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2024-10-01
Edice:	Lung Cancer: Targets and Therapy
Témata:	sclc lurbinectedin real-world evidence second line
On-line přístup:	https://www.dovepress.com/real-world-outcomes-with-lurbinectedin-in-second-line-and-beyond-for-e-peer-reviewed-fulltext-article-LCTT
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!